Literature DB >> 4704891

Nerve conduction in childhood diabetes.

J Marcus, R Ehrlich, M Kelly, E G Murphy.   

Abstract

Sixty-nine diabetic children were studied with respect to the motor nerve conduction velocities, duration of illness and adequacy of control.As a group there was a trend for children with diabetes to have slower MNCV than non-diabetic children, and for the slowing to become progressive as the duration of their disease increased. Poorer quality of diabetes control was also associated with progressive slowing of conduction but the exact relationship is uncertain, since no patient who had diabetes for more than four years was well controlled.Theories of causation of peripheral neuropathy in diabetic patients are reviewed; metabolic changes, rather than other factors, are thought most likely in children.

Entities:  

Mesh:

Year:  1973        PMID: 4704891      PMCID: PMC1941401     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  14 in total

1.  Peripheral nerve conduction in diabetic neuropathy.

Authors:  R W GILLIATT; R G WILLISON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-02       Impact factor: 10.154

2.  Diabetic neuropathy presenting as the initial clinical manifestation of diabetes.

Authors:  M ELLENBERG
Journal:  Ann Intern Med       Date:  1958-09       Impact factor: 25.391

3.  Peripheral neuropathy in juvenile diabetes.

Authors:  I Gamstorp; S A Shelburne; G Engleson; D Redondo; H S Traisman
Journal:  Diabetes       Date:  1966-06       Impact factor: 9.461

4.  Femoral nerve conduction in diabetes and chronic occlusive vascular disease.

Authors:  J S Chopra; L J Hurwitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-02       Impact factor: 10.154

5.  Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients.

Authors:  G Gregersen
Journal:  Diabetologia       Date:  1968-11       Impact factor: 10.122

6.  [Electromyography and speed of motor conduction in 150 cases of diabetes].

Authors:  A Chantraine; J P Hamoir; D Balthazar-Letawe
Journal:  Electromyography       Date:  1968 Aug-Oct

7.  Motor nerve conduction velocity in diabetes mellitus; relation with arteriosclerosis, blood sugar, arterial blood Ph, serum electrolytes and tissue temperature.

Authors:  H Wakamatsu; W Anazawa; H Hirose
Journal:  Electromyography       Date:  1967 Aug-Oct

8.  Motor-nerve conduction studies in young patients with diabetes mellitus.

Authors:  S T Khalouf; K J Olsen
Journal:  Cleve Clin Q       Date:  1967-01

9.  Diabetic neuropathy: influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity.

Authors:  G Gregersen
Journal:  Neurology       Date:  1967-10       Impact factor: 9.910

10.  The neuropathies associated with diabetes mellitus. A clinical and electromyographic study of 103 unselected diabetic patients.

Authors:  D W MULDER; E H LAMBERT; J A BASTRON; R G SPRAGUE
Journal:  Neurology       Date:  1961-04       Impact factor: 9.910

View more
  4 in total

1.  Effect of chronic renal failure, dialysis and transplantation on motor nerve conduction velocity in children.

Authors:  G S Arbus; N A Barnor; A C Hsu; E G Murphy; I C Radde
Journal:  Can Med Assoc J       Date:  1975-09-20       Impact factor: 8.262

2.  Peroneal motor nerve conduction velocity in diabetic children and adolescents. Relationships to metabolic control, HLA-DR antigens, retinopathy, and EEG.

Authors:  H Dorchy; P Noel; M Kruger; V de Maertelaer; E Dupont; D Toussaint; S Pelc
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

3.  Urinary bladder dysfunction in diabetic children with and without subclinical cardiovascular autonomic neuropathy.

Authors:  L Barkai; L Szabó
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

4.  Subclinical nerve dysfunction in children and adolescents with IDDM.

Authors:  L Hyllienmark; T Brismar; J Ludvigsson
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.